|
|
|
|
| Advertisement |
 |
|
| Advertisement |
Marketing to HCPs in the New World Order
The current COVID-19 pandemic has taken the world of healthcare provider marketing and turned it upside down. Biopharma has had to make instantaneous decisions on how to market in this new environment, who to market to, which tactics to significantly increase, and which tactics to walk away from.
Read the article
|
| Audio |
|
|
| Special Feature |
|
|
|
|
|
|
| Advertisement |
Powering HCP Promotional Precision and ROI Using AI & Predictive Analytics: A practical overview of how to use AI & ML with patient-level data to improve HCP targeting, call planning and messaging
Thursday, June 18, 2020 at 11am EDT
Register now
|
| |
| Industry update |
| //Cellectis (New York, NY), a clinical-stage biopharmaceutical company, appointed Leopold Bertea, Ph.D., to the role of Senior Vice President of Technical Operations — Europe, based in the company’s Paris, France, office.
//Galecto (Boston, MA, and Copenhagen, Denmark) a privately held biotechnology company focused on the development of novel treatments for fibrosis and cancer, announced that its Board of Directors appointed Amit Munshi as its new Chairman. The company also announced the appointment of David Shapiro M.D., former Chief Medical Officer of Intercept Pharmaceuticals, to its Board of Directors.
|
|
|
|
|
|
|
|
|
|
|
